Clinical Trial

A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated September 25, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a study assessing the feasibility of performing an anti-aging intervention which is a combination of an exercise regimen, spermidine supplementation, and either rapamycin or lamivudine.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-01.
Status change: Not Yet Recruiting → Recruiting 2025-09-21
Trial Details
NCT Number NCT07058974
Lead Sponsor Icahn School of Medicine at Mount Sinai
Conditions Smokers, Former Smokers
Enrollment 22 participants
Start Date 2025-08-25
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-25